NOVONESIS (NOVOZYMES) B (NZM2.DE) Forecast, Price Target & Analyst Ratings
FRA:NZM2 • DK0060336014
51.52 EUR
+1.16 (+2.3%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVONESIS (NOVOZYMES) B (NZM2.DE).
Forecast Snapshot
Consensus Price Target
€63.75
+ 23.74% Upside
Next Earnings Forecast
Release DateMay 5, 2026
ChartMill Buy Consensus
72.17%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€63.75
Upside
+ 23.74%
From current price of €51.52 to mean target of €63.75, Based on 23 analyst forecasts
Low
€51.40
Median
€64.20
High
€78.74
Price Target Revisions
1 Month
-1.57%
3 Months
-0.60%
Price Target Summary
23 analysts have analysed NZM2.DE and the average price target is 63.75 EUR. This implies a price increase of 23.74% is expected in the next year compared to the current price of 51.52.
The average price target has been revised downward by 0.6% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
72.17%
NZM2.DE was analyzed by 23 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about NZM2.DE.
In the previous month the buy percentage consensus was at a similar level.
NZM2.DE was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 5, 2026
Next Earnings Revisions
Revenue (1 Month)
1.88%
Revenue (3 Months)
-1.15%
EPS (1 Month)
-16.05%
EPS (3 Months)
-36.08%
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.351B 17.25% | 2.397B 1.97% | 3.834B 59.91% | 4.196B 9.46% | 4.489B 6.98% | 4.811B 7.17% | 5.244B 9.00% | 5.445B 3.83% | 5.808B 6.67% | 6.112B 5.23% | 6.425B 5.12% | 6.763B 5.26% | |
| EBITDA YoY % growth | 795.701M 11.05% | 783.915M -1.48% | 1.256B 60.27% | 1.534B 22.09% | 1.672B 9.00% | 1.816B 8.61% | 2.022B 11.34% | 2.107B 4.20% | 2.267B 7.59% | 2.389B 5.38% | 2.517B 5.36% | 2.649B 5.24% | |
| EBIT YoY % growth | 596.81M 13.33% | 597.881M 0.18% | 659M 10.22% | 968.04M 46.90% | 1.093B 12.91% | 1.233B 12.81% | 1.351B 9.57% | 1.407B 4.15% | 1.56B 10.87% | 1.66B 6.41% | 1.764B 6.27% | 1.871B 6.07% | |
| Operating Margin | 25.39% | 24.94% | 17.19% | 23.07% | 24.35% | 25.63% | 25.76% | 25.84% | 26.86% | 27.16% | 27.46% | 27.67% | |
| EPS YoY % growth | 1.77 17.51% | 1.46 -17.70% | N/A -10.56% | 1.86 32.20% | 2.03 17.73% | 2.27 11.62% | 2.53 11.35% | 2.70 6.73% | 2.95 9.24% | 3.11 5.62% | 3.29 5.75% | 3.48 5.74% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
13.53%
EPS Next 5 Year
11.28%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.71%
Revenue Next 5 Year
6.72%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
24.57%
EBIT Next 5 Year
17.53%
NOVONESIS (NOVOZYMES) B / NZM2.DE Forecast FAQ
What is the price target for NZM2 stock?
23 analysts have analysed NZM2.DE and the average price target is 63.75 EUR. This implies a price increase of 23.74% is expected in the next year compared to the current price of 51.52.
What is the next earnings date for NZM2 stock?
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-05-05.
Can you provide the expected long term growth rate for NOVONESIS (NOVOZYMES) B stock?
The expected long term growth rate for NOVONESIS (NOVOZYMES) B (NZM2.DE) is 7.71%.